Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
RVMD US​

Revolution Medicines, Inc.(RVMD US)

$186.99-0.700.37%Ext:$182.59-4.402.36%(Market Closed · 23:56:03 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings

Financials(27)

Expand
  • 10-QQ2ended 30 Jun 20265 Aug
  • 10-QQ1ended 31 Mar 20266 May
  • 10-KFY 2025ended 31 Dec 202525 Feb
  • 10-QQ3ended 30 Sept 20255 Nov 2025
  • 10-QQ2ended 30 Jun 20256 Aug 2025
  • 10-QQ1ended 31 Mar 20257 May 2025
  • 10-KFY 2024ended 31 Dec 202426 Feb 2025
  • 10-QQ3ended 30 Sept 20246 Nov 2024
  • 10-QQ2ended 30 Jun 20247 Aug 2024
  • 10-QQ1ended 31 Mar 20248 May 2024
  • 10-KFY 2023ended 31 Dec 202326 Feb 2024
  • 10-QQ3ended 30 Sept 20236 Nov 2023
  • 10-QQ2ended 30 Jun 20238 Aug 2023
  • 10-QQ1ended 31 Mar 20238 May 2023
  • 10-KFY 2022ended 31 Dec 202227 Feb 2023

Events(72)

Expand
  • 8-KCreation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant13 Oct
  • 8-KEntry into a Material Definitive Agreement1 Sep
  • 8-KOther Events26 Aug
  • 8-KResults of Operations and Financial Condition5 Aug
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers22 Jun
  • 8-KResults of Operations and Financial Condition6 May
  • 8-KEntry into a Material Definitive Agreement17 Apr
  • 8-KOther Events16 Apr
  • 8-KOther Events13 Apr
  • 8-KResults of Operations and Financial Condition25 Feb
  • 8-KResults of Operations and Financial Condition5 Nov 2025
  • 8-KOther Events17 Oct 2025
  • 8-KOther Events10 Sep 2025
  • 8-KResults of Operations and Financial Condition6 Aug 2025
  • 8-KSubmission of Matters to Shareholder Vote27 Jun 2025

Insider Ownership(408)

Expand
  • 4Statement of changes in beneficial ownership1 Oct
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership28 Sep
  • 4Statement of changes in beneficial ownership24 Sep
  • 4Statement of changes in beneficial ownership22 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership18 Sep
  • 4Statement of changes in beneficial ownership15 Sep
  • 4Statement of changes in beneficial ownership14 Sep
  • 4Statement of changes in beneficial ownership10 Sep

Beneficial Ownership(67)

Expand
  • SC 13GRevolution Medicines, Inc.14 Aug
  • SC 13G/ARevolution Medicines, Inc.13 Aug
  • SC 13GRevolution Medicines, Inc.13 Aug
  • SC 13GRevolution Medicines, Inc.29 Jul
  • SC 13G/ARevolution Medicines, Inc.15 May
  • SC 13G/ARevolution Medicines, Inc.27 Mar
  • SC 13G/ARevolution Medicines, Inc.17 Feb
  • SC 13G/ARevolution Medicines, Inc.10 Feb
  • SC 13G/ARevolution Medicines, Inc.9 Feb
  • SC 13G/ARevolution Medicines, Inc.14 Nov 2025
  • SC 13GRevolution Medicines, Inc.5 Nov 2025
  • SC 13G/ARevolution Medicines, Inc.14 Aug 2025
  • SC 13GRevolution Medicines, Inc.14 Aug 2025
  • SC 13G/ARevolution Medicines, Inc.12 Aug 2025
  • SC 13G/ARevolution Medicines, Inc.17 Jul 2025

Other Ownership(177)

Expand
  • 144Sandler Alan B.29 Sep
  • 144Mancini Anthony25 Sep
  • 144Mancini Anthony24 Sep
  • 144ANDERSON ELIZABETH M22 Sep
  • 144Mancini Anthony18 Sep
  • 144Sandler Alan B.15 Sep
  • 144Mancini Anthony15 Sep
  • 144Kelsey Stephen Michael15 Sep
  • 144Horn Margaret A15 Sep
  • 144GOLDSMITH MARK A15 Sep
  • 144Cislini Jeff15 Sep
  • 144Anders Jack15 Sep
  • 144Kelsey Stephen Michael11 Sep
  • 144Mancini Anthony10 Sep
  • 144Kim Lorence H.31 Aug

Proxies(19)

Expand
  • DEFA14ADefinitive additional materials27 Apr
  • ARSAnnual report to security holders27 Apr
  • DEF 14ADefinitive proxy statement27 Apr
  • DEFA14ADefinitive additional materials29 Apr 2025
  • ARSAnnual report to security holders29 Apr 2025
  • DEF 14ADefinitive proxy statement29 Apr 2025
  • ARSAnnual report to security holders25 Apr 2024
  • DEFA14ADefinitive additional materials25 Apr 2024
  • DEF 14ADefinitive proxy statement25 Apr 2024
  • DEFA14ADefinitive additional materials1 Nov 2023
  • DEFM14ADefinitive proxy statement (merger)29 Sep 2023
  • ARSAnnual report to security holders26 Apr 2023
  • DEF 14ADefinitive proxy statement26 Apr 2023
  • DEFA14ADefinitive additional materials26 Apr 2023
  • DEFA14ADefinitive additional materials26 Apr 2022

Registrations(54)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))15 Apr
  • 424B5Prospectus filing (Rule 424(b)(5))15 Apr
  • FWPFree writing prospectus15 Apr
  • 424B5Prospectus filing (Rule 424(b)(5))13 Apr
  • 424B5Prospectus filing (Rule 424(b)(5))13 Apr
  • 424B5Prospectus filing (Rule 424(b)(5))25 Feb
  • S-8Registration statement (employee benefit plan)25 Feb
  • S-8Registration statement (employee benefit plan)26 Feb 2025
  • 424B5Prospectus filing (Rule 424(b)(5))5 Dec 2024
  • FWPFree writing prospectus4 Dec 2024
  • 424B5Prospectus filing (Rule 424(b)(5))2 Dec 2024
  • 424B5Prospectus filing (Rule 424(b)(5))7 Aug 2024
  • S-3ASRAutomatic shelf registration statement (S-3)8 May 2024
  • S-3ASRAutomatic shelf registration statement (S-3)4 Mar 2024
  • S-8Registration statement (employee benefit plan)26 Feb 2024

Filing Review Correspondence(17)

Expand
  • CORRESPFiling review correspondence19 Apr 2024
  • CORRESPFiling review correspondence27 Sep 2023
  • CORRESPFiling review correspondence1 Feb 2021
  • CORRESPFiling review correspondence1 Feb 2021
  • CORRESPFiling review correspondence6 Jul 2020
  • CORRESPFiling review correspondence6 Jul 2020
  • CORRESPFiling review correspondence11 Feb 2020
  • CORRESPFiling review correspondence10 Feb 2020
  • CORRESPFiling review correspondence10 Feb 2020
  • UPLOADFiling review upload4 Feb 2020
  • CORRESPFiling review correspondence27 Jan 2020
  • CORRESPFiling review correspondence17 Jan 2020
  • UPLOADFiling review upload15 Jan 2020
  • DRSLTRFiling review correspondence (DRSLTR)10 Jan 2020
  • UPLOADFiling review upload5 Nov 2019

SEC Orders And Notices(4)

Expand
  • EFFECTNotice of effectiveness29 Sep 2023
  • EFFECTNotice of effectiveness3 Feb 2021
  • EFFECTNotice of effectiveness8 Jul 2020
  • EFFECTNotice of effectiveness12 Feb 2020

Trust Indenture Filings(1)

Expand
  • 305B2Application for qualification of indenture15 Apr

Exempt Offerings(3)

Expand
  • D06b15 Nov 2019
  • D06b10 Jul 2018
  • D06b21 Dec 2016

Other(4)

Expand
  • CERTCERT16 Nov 2023
  • CERTCERT11 Feb 2020
  • SEC STAFF LETTERSEC STAFF LETTER12 Nov 2019
  • SEC STAFF LETTERSEC STAFF LETTER1 Nov 2019

Financials & Metrics

FinancialsChartingShort InterestEmployees